The Chemours Company
CC
$14.12
$0.130.93%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.27% | 0.94% | -6.39% | -12.11% | 5.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.27% | 0.94% | -6.39% | -12.11% | 5.53% |
| Cost of Revenue | -3.11% | 0.08% | -0.08% | -8.90% | 1.85% |
| Gross Profit | 7.06% | 4.76% | -25.37% | -22.28% | 26.24% |
| SG&A Expenses | 49.62% | -19.26% | -18.72% | 15.32% | -23.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.28% | -1.74% | -2.62% | -6.30% | -1.79% |
| Operating Income | -50.00% | 34.55% | -34.36% | -47.25% | 4,900.00% |
| Income Before Tax | 113.04% | -330.77% | 118.94% | -61.27% | 0.00% |
| Income Tax Expenses | 132.08% | -400.00% | 121.05% | -46.43% | -289.29% |
| Earnings from Continuing Operations | 50.00% | -325.00% | 118.62% | -64.14% | 83.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.56% | -325.00% | 118.62% | -64.14% | 81.44% |
| EBIT | -50.00% | 34.55% | -34.36% | -47.25% | 4,900.00% |
| EBITDA | -25.88% | 21.51% | -26.01% | -37.37% | 136.11% |
| EPS Basic | 55.83% | -323.54% | 118.58% | -64.15% | 81.31% |
| Normalized Basic EPS | -127.63% | 45.12% | -55.79% | -64.03% | 150.91% |
| EPS Diluted | 54.04% | -325.50% | 118.24% | -64.58% | 79.91% |
| Normalized Diluted EPS | -127.63% | 46.62% | -56.00% | -63.76% | 150.91% |
| Average Basic Shares Outstanding | 0.65% | 0.72% | 0.21% | 0.03% | -0.75% |
| Average Diluted Shares Outstanding | 0.65% | -0.32% | 0.69% | -0.75% | -0.75% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -1.19% | -1.46% | 6.23% | 1.79% | -4.39% |
